Why the makers of Ozempic lost $80 billion in a day

Investors were so enthusiastic about Ozempic that in 2024 its maker Novo Nordisk was the most valuable company in Europe — but this week, it lost more than 20% of its value in one day. Elena Casas explains why. #novonordisk #ozempic #wegovy #stockmarket #pharmaceuticals #investing Read the story here: 👉 Subscribe: http://smarturl.it/reuterssubscribe Keep up with the latest news from around the world: https://www.reuters.com/ Follow Reuters on Facebook: https://www.facebook.com/Reuters Follow Reuters on Twitter: https://twitter.com/Reuters Follow Reuters on Instagram: https://www.instagram.com/reuters/?hl=en